University of Iowa Research Foundation received U.S. patents for CMV promoter
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
Biotechnology | NIH | Oncology | Therapeutics
The Indiana University Cancer Center was founded
In 1992, The Indiana University (IU) Cancer Center, now known as the IU Melvin and Bren Simon Comprehensive…
Elizabeth Gould of Princeton University published observations of neurogenesis in the adult brain
In 1992, Elizabeth Gould of Princeton University published observations of neurogenesis in the adult brain. Her initial observations…
Bristol-Myers Squibb’s antibiotic, CEFZIL (cefprozil) was approved by the US Food and Drug Administration
In 1992, Bristol-Myers Squibb’s antibiotic, CEFZIL (cefprozil) was approved by the U.S. Food and Drug Administration.
The School of Nursing building opened at OHSU
In 1992, the Oregon Health Science University (OHSU) School of Nursing building opened its doors. The building, located…
OHSU’s Center for Research on Occupational and Environmental Toxicology building opened
In 1992, the Center for Research on Occupational and Environmental Toxicology (CROET) building opened on the Oregon Health…
Riverfront Research Park at the University of Oregon dedicated its first building
In 1992, Riverfront Research Park at the University of Oregon dedicated its first building. The Research Park is…
OHSU President Peter O Kohler, MD appointed Grover Bagby, MD, director of the Oregon Cancer Center
In 1992, Oregon Health & Science University (OHSU) President Peter O. Kohler, M.D. announced the appointment of Grover…
The Oregon Cancer Center was founded at Oregon Health & Science University
In 1992, the Oregon Cancer Center, later known as the OHSU Cancer Institute, was founded at Oregon Health…
The Virginia Biotechnology Association was founded
In 1992, Virginia Biotechnology Association (VaBIO) was founded as a non-profit association that promotes the biotechnology industry in…
Dendreon Corporation was founded
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…